RN given refers to all (L)-isomer; RN for cpd without isomeric designation not avail 2/92
Also Known As:
Cys-Tyr; N-L-cysteinyl-L-tyrosine
Networked: 14 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results


1. Srivastava, Sudha: 2 articles (08/2004 - 08/2003)
2. Chen, Lih Chi: 1 article (10/2013)
3. Shih, Mei Fen: 1 article (10/2013)
4. Cherng, Jong Yuh: 1 article (10/2013)
5. Liu, C C: 1 article (07/2010)
6. Shen, C R: 1 article (07/2010)
7. Lin, H H: 1 article (07/2010)
8. Shih, M F: 1 article (07/2010)
9. Cherng, J Y: 1 article (07/2010)
10. de Jong, Marion: 1 article (01/2006)

Related Diseases

1. Atherosclerosis
2. Neoplasms (Cancer)
01/01/2006 - "To alter the elimination route, we examined the biodistribution of radioiodinated RGD-octreotate without DTPA [c(Arg-Gly-Asp-D-Tyr-Asp)-D-Phe-c(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr], as a model of unlabeled RGD-octreotate, in tumor-bearing rats. "
08/01/2004 - "Lanreotide, [beta-naphthyl-Ala-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2] a disulfide-linked cyclic octapeptide and a somatostatin analog, reported to bind with a wide variety of tumors expressing somatostatin receptors, was conjugated with DOTA. "
11/01/1999 - "Phe-Leu-Gly-Phe-Pro-Thr (MP-1) manifests an immunocorrecting effect by restoring the level of antibody production in animals suffering from immunodeficiencies of various etiologies; Leu-Val-Val-Tyr-Pro-Trp (MP-2) manifests an antitumor effect by abolishing the inhibitory action of tumor cells on the functional activity of T-lymphocytes; Leu-Val-Cys-Tyr-Pro-Gln (MP-3) stimulates phagocytosis by macrophages and, in this way, protects animals from infections caused by pathogenic microorganisms; and Phe-Pro-Arg-Ile-Met-Thr-Pro (MP-4) is a new factor of cell differentiation inducing terminal cell differentiation in the HL-60 and K-562 leukemic cell lines."
01/01/1992 - "The effects of treatment with a bombesin receptor antagonist [D-Tpi6, Leu13 psi (CH2NH) Leu14]BN(6-14)(RC-3095) and the combination of an agonist of luteinizing hormone-releasing hormone [D-Trp6]-LH-RH and somatostatin analog D-Phe-Cys-Tyr-D-Trp-Lys-Val- Cys-Trp-NH2 (RC-160) were studied in nude mice bearing xenografts of the hormone-dependent human prostate tumor PC-82. "
3. Infection
4. Multiple Endocrine Neoplasia Type 2b (MEN 3)
5. Multiple Endocrine Neoplasia Type 2a (MEN 2)

Related Drugs and Biologics

1. arginylproline
2. glycylproline (Gly-Pro)
3. Somatostatin (Somatotropin Release-Inhibiting Factor)
4. Peptides
5. lysylvaline (Lys-Val)
6. Presenilins
7. Bombesin Receptors (Bombesin Receptor)
8. Somatostatin Receptors (Somatostatin Receptor)
9. mu Opioid Receptors (mu Opioid Receptor)
10. Transforming Growth Factor beta (TGF-beta)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)